114 related articles for article (PubMed ID: 9846888)
1. Effects of continuous ambulatory peritoneal dialysis and kidney transplantation on advanced glycation endproducts in the skin and peritoneum.
Shaw S; Akyol M; Bell J; Briggs JD; Dominiczak MH
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1061-8. PubMed ID: 9846888
[TBL] [Abstract][Full Text] [Related]
2. Kidney transplantation decreases the tissue level of advanced glycosylation end-products.
Lee WK; Akyol M; Shaw S; Dominiczak MH; Briggs JD
Nephrol Dial Transplant; 1995; 10(1):103-7. PubMed ID: 7724002
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure.
Yamada K; Miyahara Y; Hamaguchi K; Nakayama M; Nakano H; Nozaki O; Miura Y; Suzuki S; Tuchida H; Mimura N
Clin Nephrol; 1994 Dec; 42(6):354-61. PubMed ID: 7882598
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of furosine and pentosidine in CAPD patients.
Kumano K; Yokota S; Sakai T; Kobayashi N; Yoshida A; Yoshihara T; Shibata K; Izumi G; Wang H
Adv Perit Dial; 1997; 13():53-7. PubMed ID: 9360651
[TBL] [Abstract][Full Text] [Related]
5. Effect of the peritoneal dialysis prescription on pentosidine in children.
Bayazit AK; Vogt BA; Dell KM; Davis ID; Noyan A; Anarat A; Avner ED; Erhard P; Weiss MF
Pediatr Nephrol; 2003 Oct; 18(10):1049-54. PubMed ID: 12898376
[TBL] [Abstract][Full Text] [Related]
6. Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy.
Miyata T; Ueda Y; Yoshida A; Sugiyama S; Iida Y; Jadoul M; Maeda K; Kurokawa K; van Ypersele de Strihou C
Kidney Int; 1997 Mar; 51(3):880-7. PubMed ID: 9067925
[TBL] [Abstract][Full Text] [Related]
7. Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation.
Hricik DE; Wu YC; Schulak A; Friedlander MA
Clin Transplant; 1996 Dec; 10(6 Pt 1):568-73. PubMed ID: 8996781
[TBL] [Abstract][Full Text] [Related]
8. Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
Verzijl N; DeGroot J; Oldehinkel E; Bank RA; Thorpe SR; Baynes JW; Bayliss MT; Bijlsma JW; Lafeber FP; Tekoppele JM
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):381-7. PubMed ID: 10947951
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
[TBL] [Abstract][Full Text] [Related]
10. Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis.
Shioshita K; Miyazaki M; Ozono Y; Abe K; Taura K; Harada T; Koji T; Taguchi T; Kohno S
Kidney Int; 2000 Feb; 57(2):619-31. PubMed ID: 10652040
[TBL] [Abstract][Full Text] [Related]
11. Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease.
Friedlander MA; Wu YC; Schulak JA; Monnier VM; Hricik DE
Am J Kidney Dis; 1995 Mar; 25(3):445-51. PubMed ID: 7872323
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of cross-linking advanced glycation endproducts in long-term CAPD peritoneal degeneration.
Nakayama M; Yoshimura K; Maruyama Y; Numata M; Hosoya T; Izumi G
Nephrol Dial Transplant; 2004 Jun; 19(6):1664-5. PubMed ID: 15150373
[No Abstract] [Full Text] [Related]
13. Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease.
Hartog JW; de Vries AP; Lutgers HL; Meerwaldt R; Huisman RM; van Son WJ; de Jong PE; Smit AJ
Ann N Y Acad Sci; 2005 Jun; 1043():299-307. PubMed ID: 16037252
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD.
Nakayama M; Kawaguchi Y; Yamada K; Hasegawa T; Takazoe K; Katoh N; Hayakawa H; Osaka N; Yamamoto H; Ogawa A; Kubo H; Shigematsu T; Sakai O; Horiuchi S
Kidney Int; 1997 Jan; 51(1):182-6. PubMed ID: 8995732
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo generation and kinetics of glycosylation products in peritoneal dialysis effluents.
Yokota S; Kumano K; Hyodo T; Sakai T; Izumi G; Hashimoto A; Shibata K; Wang H
Adv Perit Dial; 1998; 14():195-9. PubMed ID: 10649723
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysis.
Bonnefont-Rousselot D; Jaudon MC; Issad B; Cacoub P; Congy F; Jardel C; Delattre J; Jacobs C
Nephrol Dial Transplant; 1997 Jul; 12(7):1399-405. PubMed ID: 9249776
[TBL] [Abstract][Full Text] [Related]
18. Role of advanced glycation end products and growth factors in peritoneal dysfunction in CAPD patients.
Nakamura S; Tachikawa T; Tobita K; Miyazaki S; Sakai S; Morita T; Hirasawa Y; Weigle B; Pischetsrieder M; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S61-7. PubMed ID: 12612955
[TBL] [Abstract][Full Text] [Related]
19. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of an AGE, a ligand for macrophage receptor, in peritoneum of CAPD patients.
Nakamura S; Tobita K; Tachikawa T; Akamatsu S; Ohno Y; Kan A; Katsuragawa M; Yasumura K; Miyazaki S; Sakai S; Morita T; Hirashawa Y; Niwa T
Kidney Int Suppl; 2003 May; (84):S152-7. PubMed ID: 12694334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
